SCHEMBL13226830

SCHEMBL13226830

CNC(=O)c1occc(=O)c1OCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.60
GAA P10253 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.46
KCNA2 P16389 1/20 0.44
KCNA5 P22460 1/20 0.44
KCNA1 Q09470 1/20 0.44
GPR55 Q9Y2T6 1/20 0.44
MAOB P27338 2/20 0.44
POLB P06746 1/20 0.44
KCNA3 P22001 1/20 0.44
MAOA P21397 1/20 0.43
HPGD P15428 2/20 0.43
BRD4 O60885 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HTT P42858 1/20 0.41
MMP1 P03956 1/20 0.41
MMP3 P08254 1/20 0.41
MMP7 P09237 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23223241 0.87 LMNA (0.58) LMNAGAASMN1; SMN2KCNA2KCNA5
SCHEMBL21975951 0.86 LMNA (0.56) LMNAGAASMN1; SMN2KCNA2KCNA5
SCHEMBL4545464 0.85 LMNA (0.62) LMNAGAASMN1; SMN2KCNA2KCNA5
SCHEMBL86223 0.85 LMNA (0.64) LMNAGAASMN1; SMN2KCNA2KCNA5
SCHEMBL13395926 0.83 GAA (0.52) LMNAGAASMN1; SMN2KCNA2KCNA5
SCHEMBL14129739 0.82 LMNA (0.61) LMNAGAASMN1; SMN2KCNA2KCNA5
SCHEMBL19329810 0.82 LMNA (0.58) LMNAGAASMN1; SMN2KCNA2KCNA5
SCHEMBL10030589 0.82 GAA (0.51) LMNAGAASMN1; SMN2KCNA2KCNA5
SCHEMBL19329825 0.81 LMNA (0.56) LMNAGAASMN1; SMN2KCNA2KCNA5
SCHEMBL10030597 0.81 LMNA (0.50) LMNAGAAKCNA2KCNA5KCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7786316-B2 Metalloprotein inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-08-31 US disclosed
US-20090286987-A1 METALLOPROTEIN INHIBITORS REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO UCSD TECHNOLOGY TRANSFER OFFICE (US) 2009-11-19 US disclosed
US-7579486-B2 Metalloprotein inhibitors REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO (US) 2009-08-25 US disclosed
US-20070117848-A1 METALLOPROTEIN INHIBITORS REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO 2007-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286987-A1 METALLOPROTEIN INHIBITORS SOD1, ZFX, SOD3 LMNA 3336/4885GAA 156/4885SMN1; SMN2 3424/4885
US-20070117848-A1 METALLOPROTEIN INHIBITORS SOD1, ZFX, SOD3 LMNA 3336/4885GAA 156/4885SMN1; SMN2 3424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.